NF-kappa-B is a homo- or heterodimeric protein complex, a pleiotropic transcription factor that is present in almost all cell types and is the endpoint of a series of signal transduction events triggered by a variety of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis.
NF-kappa-B
DefinitionThis section has been translated automatically.
General informationThis section has been translated automatically.
The complex is formed by proteins that contain Rel-like domains, such as RELA/p65 (see RELA gene below), RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind to kappa B sites in the DNA of their target genes. The individual dimers have different preferences for different kappa B sites, which they can bind with different affinity and specificity.
The transcription factor NF-kappa-B (NFKB) is activated by various intra- and extracellular stimuli such as cytokines, oxidative free radicals, ultraviolet radiation and bacterial or viral products. Activated NF-kappa-B migrates into the cell nucleus and stimulates the expression of genes involved in a variety of biological functions.
Uncontrolled activation of NF-kappa-B (NFKB) has been associated with a number of inflammatory diseases, while prolonged inhibition of NFKB leads to defective immune cell development or delayed cell growth. NFKB is a key regulator of the immediate and early response to viral infection.
LiteratureThis section has been translated automatically.
- Bergbreiter A et al.(2021) Recurrent necrotizing cellulitis, multi-organ autoimmune disease and humoral immunodeficiency due to a novel NFKB1 frameshift mutation. Eur J Med Genet64:104144.
- Fang R et al. (2021) Case report: a novel mutation in associated with pyoderma gangrenosum. Front Genet 12:673453.
- Finck A et al. (2006) Linkage of autosomal-dominant common variable immunodeficiency to chromosome 4q. Europ J Hum Genet. 14: 867-875
- Fliegauf M et al. (2015) Haploinsufficiency of the NF-kappaB1 subunit p50 in common variable immunodeficiency. Am J Hum Genet. 97: 389-403.
- Lorenzini T et al. (2020) Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations. J Allergy Clin Immun 146: 901-911.
- Nijenhuis T et al. (2001) Common variable immunodeficiency (CVID) in a family: an autosomal dominant mode of inheritance. Neth J Med 59: 134-139.
- Schipp C et al. (2016) Specific antibody deficiency and autoinflammatory disease extend the clinical and immunological spectrum of heterozygous NFKB1 loss-of-function mutations in humans. Haematologica 101: e392-e396.
- Tuijnenburg Pet al. (2018) Loss-of-function nuclear factor kappaB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans. J Allergy Clin Immun 142: 1285-1296.